Advertisement
Singapore markets close in 2 hours 8 minutes

  • Straits Times Index

    3,406.20
    +38.30 (+1.14%)
     

  • Nikkei

    40,580.76
    +506.07 (+1.26%)
     

  • Hang Seng

    17,958.71
    +189.57 (+1.07%)
     

  • FTSE 100

    8,121.20
    -45.56 (-0.56%)
     

  • Bitcoin USD

    60,924.85
    -1,887.54 (-3.01%)
     

  • CMC Crypto 200

    1,314.34
    -20.58 (-1.54%)
     

  • S&P 500

    5,509.01
    +33.92 (+0.62%)
     

  • Dow

    39,331.85
    +162.33 (+0.41%)
     

  • Nasdaq

    18,028.76
    +149.46 (+0.84%)
     

  • Gold

    2,344.40
    +11.00 (+0.47%)
     

  • Crude Oil

    83.22
    +0.41 (+0.50%)
     

  • 10-Yr Bond

    4.4360
    -0.0430 (-0.96%)
     

  • FTSE Bursa Malaysia

    1,608.38
    +10.42 (+0.65%)
     

  • Jakarta Composite Index

    7,147.05
    +21.90 (+0.31%)
     

  • PSE Index

    6,440.21
    +81.25 (+1.28%)
     

Lineage Cell: Q1 Earnings Snapshot

Associated Press Finance
·1-min read

CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Lineage Cell Therapeutics, Inc. (LCTX) on Thursday reported a loss of $6.5 million in its first quarter.

On a per-share basis, the Carlsbad, California-based company said it had a loss of 4 cents.

The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 4 cents per share.

The biotechnology company posted revenue of $1.4 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LCTX at https://www.zacks.com/ap/LCTX